OneMedNet Corporation (NASDAQ:ONMD) Short Interest Update

OneMedNet Corporation (NASDAQ:ONMD) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 423,841 shares, an increase of 93.6% from the November 30th total of 218,963 shares. Currently, 1.5% of the company’s shares are short sold. Based on an average daily trading volume, of 763,417 shares, the short-interest ratio is currently 0.6 days. Based on an average daily trading volume, of 763,417 shares, the short-interest ratio is currently 0.6 days. Currently, 1.5% of the company’s shares are short sold.

Insider Transactions at OneMedNet

In other OneMedNet news, Director Eric Casaburi acquired 10,000 shares of the stock in a transaction dated Wednesday, October 15th. The stock was acquired at an average price of $3.05 per share, with a total value of $30,500.00. Following the completion of the purchase, the director owned 65,475 shares in the company, valued at $199,698.75. This trade represents a 18.03% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Aaron Green sold 64,767 shares of OneMedNet stock in a transaction that occurred on Wednesday, October 22nd. The shares were sold at an average price of $2.23, for a total transaction of $144,430.41. Following the completion of the transaction, the chief executive officer owned 1,865,658 shares of the company’s stock, valued at $4,160,417.34. This trade represents a 3.36% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 46.20% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ONMD. Exencial Wealth Advisors LLC boosted its holdings in shares of OneMedNet by 3.1% in the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock valued at $851,000 after acquiring an additional 45,448 shares during the period. Ashton Thomas Private Wealth LLC purchased a new stake in OneMedNet in the 3rd quarter valued at $25,000. Finally, Correct Capital Wealth Management acquired a new stake in OneMedNet during the 3rd quarter worth $4,910,000. Institutional investors and hedge funds own 0.95% of the company’s stock.

OneMedNet Stock Performance

ONMD stock traded down $0.06 during midday trading on Friday, reaching $1.27. 505,833 shares of the company were exchanged, compared to its average volume of 2,268,701. The company has a market cap of $64.78 million, a price-to-earnings ratio of -25.40 and a beta of 1.10. OneMedNet has a 1-year low of $0.30 and a 1-year high of $4.22. The stock’s 50-day simple moving average is $1.66 and its 200 day simple moving average is $1.16.

OneMedNet (NASDAQ:ONMD) last posted its earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.18 million for the quarter.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of OneMedNet in a research note on Tuesday, October 14th. Wall Street Zen upgraded shares of OneMedNet to a “hold” rating in a report on Friday, September 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, OneMedNet currently has a consensus rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.